BIO-PATH HOLDINGS, INC.

For the period ended Dec 31, 2024. Filed Mar 27, 2025.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2024 · Filed Mar 27, 2025

BPTH$0.21-66.8%Stored close · as of Feb 18, 2025

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Balance Sheets

(In thousands, except par value)


· As of December 31, · As of December 31,
· · 2024 · · 2023

Assets · ·
· ·
Current assets · ·
Cash	$1,173	$1,052
Prepaid drug product	1,074	632
Other current assets	1,529	1,358
Total current assets	3,776	3,042

Fixed assets
Furniture, fixtures & equipment	1,077	1,120
Less accumulated depreciation	(1,054)	(1,044)
	23	76

Right of use operating assets	84	102

Total Assets	$3,883	$3,220
Liabilities & Shareholders' Equity
Current liabilities
Accounts payable	$1,274	$457
Accrued expenses	1,938	1,346
Current portion of lease liabilities	83	103
Total current liabilities	3,295	1,906

Warrant liability	434	863

Noncurrent lease liabilities	—	10

Total Liabilities	3,729	2,779

Shareholders' equity
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	—	—
Common stock, $.001 par value; 200,000 shares authorized; 5,768 and 618 shares issued and outstanding, respectively	6	1
Additional paid in capital	117,649	108,047
Accumulated deficit	(117,501)	(107,607)
Total shareholders' equity	154	441
Total Liabilities & Shareholders' Equity	$3,883	$3,220

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.